The Efficacy of Machine Learning Models for Predicting the Prognosis of Heart Failure: A Systematic Review and Meta-Analysis.

IF 1.9 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Cardiology Pub Date : 2024-04-22 DOI:10.1159/000538639
Zhaohui Xu, Yinqin Hu, Xinyi Shao, Tianyun Shi, Jiahui Yang, Qiqi Wan, Yongming Liu
{"title":"The Efficacy of Machine Learning Models for Predicting the Prognosis of Heart Failure: A Systematic Review and Meta-Analysis.","authors":"Zhaohui Xu, Yinqin Hu, Xinyi Shao, Tianyun Shi, Jiahui Yang, Qiqi Wan, Yongming Liu","doi":"10.1159/000538639","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nHeart failure (HF) is a major global public health concern. The application of machine learning (ML) to identify individuals at high risk and enable early intervention is a promising approach for improving HF prognosis. We aim to systematically evaluate the performance and value of ML models for predicting HF prognosis.\n\n\nMETHODS\nPubMed, Web of Science, Scopus, and Embase online databases were searched up to April 30, 2023, to identify studies on the use of ML models to predict HF prognosis. HF prognosis primarily encompasses readmission and mortality. The meta-analysis was conducted by MedCalc software. Subgroup analyses include grouping based on types of ML models, time interval, sample sizes, the number of predictive variables, validation methods, whether to conduct hyperparameter optimization and calibration, data set partitioning methods.\n\n\nRESULTS\nA total of 31 studies were included. The most common ML models were random forest, boosting, support vector machine, neural network. The area under the receiver operating characteristic curve (AUC) for predicting HF readmission was 0.675 (95% CI 0.651-0.699, P<0.001), and the AUC for predicting HF mortality was 0.790 (95% CI 0.765-0.816, P<0.001). Subgroup analyses revealed that models with the prediction time interval of 1 year, sample sizes =10,000, the number of predictive variables =100, external validation, hyperparameter tuning, calibration adjustment, and data set partitioning using 10-fold cross-validation exhibited favorable performance within their respective subgroups.\n\n\nCONCLUSION\nThe performance of ML models in predicting HF readmission is relatively poor, while its performance in predicting HF mortality is moderate. The quality of the relevant studies is generally low, it is essential to enhance the predictive capabilities of ML models through targeted improvements in practical applications.","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000538639","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION Heart failure (HF) is a major global public health concern. The application of machine learning (ML) to identify individuals at high risk and enable early intervention is a promising approach for improving HF prognosis. We aim to systematically evaluate the performance and value of ML models for predicting HF prognosis. METHODS PubMed, Web of Science, Scopus, and Embase online databases were searched up to April 30, 2023, to identify studies on the use of ML models to predict HF prognosis. HF prognosis primarily encompasses readmission and mortality. The meta-analysis was conducted by MedCalc software. Subgroup analyses include grouping based on types of ML models, time interval, sample sizes, the number of predictive variables, validation methods, whether to conduct hyperparameter optimization and calibration, data set partitioning methods. RESULTS A total of 31 studies were included. The most common ML models were random forest, boosting, support vector machine, neural network. The area under the receiver operating characteristic curve (AUC) for predicting HF readmission was 0.675 (95% CI 0.651-0.699, P<0.001), and the AUC for predicting HF mortality was 0.790 (95% CI 0.765-0.816, P<0.001). Subgroup analyses revealed that models with the prediction time interval of 1 year, sample sizes =10,000, the number of predictive variables =100, external validation, hyperparameter tuning, calibration adjustment, and data set partitioning using 10-fold cross-validation exhibited favorable performance within their respective subgroups. CONCLUSION The performance of ML models in predicting HF readmission is relatively poor, while its performance in predicting HF mortality is moderate. The quality of the relevant studies is generally low, it is essential to enhance the predictive capabilities of ML models through targeted improvements in practical applications.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
机器学习模型在预测心力衰竭预后方面的功效:系统回顾与元分析》。
导言心力衰竭(HF)是全球关注的主要公共卫生问题。应用机器学习(ML)识别高危人群并进行早期干预是改善心力衰竭预后的有效方法。我们旨在系统评估 ML 模型预测 HF 预后的性能和价值。方法检索了截至 2023 年 4 月 30 日的 Web of Science、Scopus 和 Embase 在线数据库,以确定使用 ML 模型预测 HF 预后的研究。心房颤动预后主要包括再入院率和死亡率。荟萃分析由 MedCalc 软件进行。分组分析包括基于 ML 模型类型、时间间隔、样本大小、预测变量数量、验证方法、是否进行超参数优化和校准、数据集划分方法的分组。最常见的 ML 模型是随机森林、提升、支持向量机和神经网络。预测高频再入院的接收者操作特征曲线下面积(AUC)为 0.675(95% CI 0.651-0.699,P<0.001),预测高频死亡率的接收者操作特征曲线下面积(AUC)为 0.790(95% CI 0.765-0.816,P<0.001)。亚组分析显示,预测时间间隔为 1 年、样本量=10,000、预测变量数=100、外部验证、超参数调整、校准调整和使用 10 倍交叉验证进行数据集划分的模型在各自亚组中表现出良好的性能。相关研究的质量普遍较低,因此在实际应用中必须通过有针对性的改进来提高 ML 模型的预测能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cardiology
Cardiology 医学-心血管系统
CiteScore
3.40
自引率
5.30%
发文量
56
审稿时长
1.5 months
期刊介绍: ''Cardiology'' features first reports on original clinical, preclinical and fundamental research as well as ''Novel Insights from Clinical Experience'' and topical comprehensive reviews in selected areas of cardiovascular disease. ''Editorial Comments'' provide a critical but positive evaluation of a recent article. Papers not only describe but offer critical appraisals of new developments in non-invasive and invasive diagnostic methods and in pharmacologic, nutritional and mechanical/surgical therapies. Readers are thus kept informed of current strategies in the prevention, recognition and treatment of heart disease. Special sections in a variety of subspecialty areas reinforce the journal''s value as a complete record of recent progress for all cardiologists, internists, cardiac surgeons, clinical physiologists, pharmacologists and professionals in other areas of medicine interested in current activity in cardiovascular diseases.
期刊最新文献
Gender Differences in Cardiovascular Disease: Perspectives on Disparities in Women's Treatment and Outcomes. Meta-analysis of the efficacy and safety of radiofrequency catheter ablation for pediatric paroxysmal supraventricular tachycardia. Floppy Mitral Valve/Mitral Valve Prolapse and Manifestations Not Related to Mitral Regurgitation: Time to Search the Dark Side of the Moon. Impact of an exercise-based cardiac rehabilitation program on cardiopulmonary test parameters. Prevalence and predictors of thromboembolic events in patients with left ventricular dysfunction and left ventricular thrombus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1